Market Tracker

12/06 10:56am ET

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

367.68
BATS BZX Real-Time Price
As of 10:53am ET
 -2.14 / -0.58%
Today’s Change
325.35
Today|||52-Week Range
563.79
-32.27%
Year-to-Date
Play the Trump Factor with these 4 Large-Cap Stocks
10:50am / Zacks.com - Paid Partner Content
Buy 7 Stocks with Impressive Interest Coverage Ratio
Dec 01 / Zacks.com - Paid Partner Content
Here's Why Regeneron Pharmaceuticals, Inc. Jumped 9.4% in November
Dec 05 / MotleyFool.com - Paid Partner Content
NVIDIA, Sotheby's Holdings, Celgene, Regeneron Pharmaceuticals and Sanofi highlighted...
Nov 30 / Zacks.com - Paid Partner Content
Jim Cramer's 'Mad Money' Recap: How to Handle Your Finances at Any Age
Dec 02 / TheStreet.com - Paid Partner Content
Celgene vs. Regeneron: Which Stock is a Better Pick?
Nov 29 / Zacks.com - Paid Partner Content
5 Top Performing Biotechnology Stocks of November
Dec 01 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: Acorda Stops Ampyra PSWD Development, CRL for Spectrum's Qapzo...
Nov 23 / Zacks.com - Paid Partner Content
What Regeneron's CEO Thinks About Drug Pricing Under Trump
Dec 01 / TheStreet.com - Paid Partner Content
3 Biotechs That Don't Pay Dividends -- but Could
Nov 22 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close369.82
Today’s open371.11
Day’s range366.47 - 371.11
Volume3,237
Average volume (3 months)829,529
Market cap$39.0B
Dividend yield--
Data as of 10:53am ET, 12/06/2016

Growth & Valuation

Earnings growth (last year)+79.80%
Earnings growth (this year)-3.14%
Earnings growth (next 5 years)+16.00%
Revenue growth (last year)+45.55%
P/E ratio53.7
Price/Sales15.24
Price/Book10.59

Competitors

 Today’s
change
Today’s
% change
ALXNAlexion Pharmaceutic...-0.35-0.28%
SHPGShire-2.16-1.22%
ZTSZoetis Inc-0.17-0.34%
BAXBaxter International...-0.28-0.64%
Data as of 10:56am ET, 12/06/2016

Financials

Next reporting dateFebruary 14, 2017
EPS forecast (this quarter)$3.13
Annual revenue (last year)$4.1B
Annual profit (last year)$636.1M
Net profit margin15.50%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO &
Class I Director
Leonard S. Schleifer
Chief Financial Officer &
Senior VP-Finance
Robert E. Landry
Corporate headquarters
Tarrytown, New York

Forecasts